RE:DIABETES CASES QUADRUPLE Hi Jkj. Thanks for the link.
The diabetes ML and obesity relationship has been all over the media lately and of course has been well known by Resverlogix, Hepalink (based in China
where diabetes mellitus is out of control and increasing), Eastern Capital and NGN for a number of years.
As we know, Resverlogix is exactly in the right position to capitalze on this with apabetalone (rvx-208) with it's 77% relative risk reduction (absolute risk reduction of 16% points = 21% - 5%) within patients with diabetes mellitus, CVD and low HDL.
The diabetes mellitus, obesity and CVD problem is an extremely costly health care issue throughout the world and it will continue to grow. As the article indicates people must eat properly, excercise and reduce theiir weight.
- This will not happen...people do not have the time, effort and will power to do it. Fried foods consumed with soda drinks with massive amounts of sugar will continue to fatten up the American population (and many other countries) and cause stress on their pancrease(s).
Therefore, fortunately for me and long share holders, the solution to avoiding MACE (major cardiovascular events) with be statins (Crestor - rosuvastatin) for LDL reduction in combination with apabetalone (rvx-208) to boast ApoA-l the most dominant component of
functional HDL. As we know apabetalone impacts multiple pathways including modulating gene transcription and has effects on pathways known to play important roles in CVD risks including the complement, coagulation, inflammation, and metabolism as well as increasing levels of the apolipoprotein A-I (apoAI), the major protein in high density lipoprotein(HDL) resulting in reverse cholesterol transport.
From the article - Type 2 diabetes is a long-term condition characterized by insulin resistance. Patients can manage their diabetes with medication and diet, but the disease is often life-long and is a major cause of blindness, kidney failure, heart attacks, stroke and lower limb amputation.
"Obesity is the most important risk factor for type 2 diabetes and
our attempts to control rising rates of obesity have so far not proved successful," said Majid Ezzati, a professor at Imperial College London who led the WHO research.
It is a very unfortunate problem from a health perspective. However, for me as an investor I think it will prove to be an extremely fortunate opportunity to make a ton of money!!!
Anyway, all IMHO and GLTA.
Cheers
Toinv